BN Business News
Add your company to Business Communicator →

Business · 06/10/2026

FDA Classifies Hyperoxia Monitoring Device Adjunct to Pulse Oximetry as Class II Device with Special Controls

The US Food and Drug Administration (FDA) has classified the hyperoxia monitoring device adjunct to pulse oximetry into Class II, a category requiring special controls to ensure safe and effective use, following a review of the device's safety and effectiveness

Source: Federal Register — Health and Human ServicesOpen original release →